PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Indonesia · Delayed Price · Currency is IDR

1,570.00

0.00 (0.00%)

Oct 30, 2026, 3:48 PM WIB

Market Cap	1.76T -7.9%
Revenue (ttm)	2.45T +15.5%
Net Income	142.29B -17.8%
EPS	126.58 -18.2%
Shares Out	1.12B
PE Ratio	12.40
Forward PE	n/a
Dividend	105.00 (6.69%)
Ex-Dividend Date	Jun 30, 2026

Volume	7,500
Open	1,575.00
Previous Close	1,570.00
Day's Range	1,560.00 - 1,575.00
52-Week Range	1,420.00 - 1,695.00
Beta	-0.06
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 3, 2026

About IDX:DVLA

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1976

Employees 1,357

Stock Exchange Indonesia Stock Exchange

Ticker Symbol DVLA

Full Company Profile

Financial Performance

In 2025, IDX:DVLA's revenue was 2.23 trillion, an increase of 6.90% compared to the previous year's 2.09 trillion. Earnings were 163.95 billion, an increase of 5.00%.

Financial Statements